Parkinson's Disease

Study Results May Change the Way Physicians Treat Early Stage Disease

Published in Neurological Diseases and Disorders Weekly, June 1st, 2000

SmithKline Beecham's Requip (ropinirole hydrochloride) successfully managed Parkinson's disease symptoms for up to five years with a low risk of developing dyskinesia, according to a study published in the May 18, 2000, issue of The New England Journal of Medicine.

Dyskinesias are severe, uncontrollable, jerky body movements that plague many Parkinson's disease patients and in many cases are associated with levodopa therapy.

Levodopa has been the "gold standard" of treatment in Parkinson's disease for the past 35 years; it is used in approximately 75% of patients. Unfortunately, over time Parkinson's disease progresses and physicians need...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Neurological Diseases and Disorders Weekly

Source: Neurological Diseases and Disorders Weekly (2000-06-01)

More Articles from Neurological Diseases and Disorders Weekly

Alzheimer's Disease
Triggering Enzyme Identified
Alzheimer's Disease
Circadian Rhythm Disturbances Located in the Suprachiasmatic Nucleus
Animal Models
Rat Anatomy Textbooks May Be Wrong About Spinal Nerves
Antinociception
Melatonin Pain Relief is Mediated by MT2 Receptors
Attention Deficit/Hyperactivity Disorder
Adderall More Effective than Methylphenidate in Reducing Symptoms
Brain Function
Researchers Discover New Synapses
More from this issue of Neurological Diseases and Disorders Weekly

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry